Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Systematic Review

Published on 08 Jan 2025

Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials

in Drugs Outcomes Research and Policies

Weijie Fu
Maolin Zhao
Sheng Ding
Mei Xin
Ke Yang
Li Jiang
Fan Wu
Xiaochen Wu
Jian Wang
Jie Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519869

1,957 views

Original Research

Published on 07 Jan 2025

Appropriateness and inappropriate medication predictors of stress ulcer prophylaxis in the intensive care unit

in Drugs Outcomes Research and Policies

Pan Zhang
Siyang Wang
Tingting Zhi
Naobei Ye
Haonan Sun
Xingyu Qin
Shuhan Xu
Ruiqin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401335

956 views

Original Research

Published on 07 Jan 2025

Analysis of factors influencing the awareness of inpatients regarding hospital clinical pharmacy services and willingness to pay: a multicenter survey in Hebei Province, China

in Drugs Outcomes Research and Policies

Ruixia Yang
Xin Wang
Huizhen Wu
Qian Sun
Sijie Zhang
Qian Dong
Mengjiao Li
Xiaoli Xu
Jing Bai
Ping Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1520058

937 views

Original Research

Published on 07 Jan 2025

Doctor, what is my risk of bleeding after cardiac surgery while on combined anticoagulant with antiplatelet therapy? A validated nomogram for risk assessment

in Drugs Outcomes Research and Policies

Haolong Han
Hang Xu
Jifan Zhang
Weihui Zhang
Yi Yang
Xia Wang
Li Wang
Dongjin Wang
Weihong Ge

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1528390

979 views

Original Research

Published on 07 Jan 2025

Analysis of drug pricing drivers under South Korea’s pharmaco-economic evaluation exemption policy (2015–2022)

in Drugs Outcomes Research and Policies

Seung Rae Yu
Jong Hyuk Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519491

1,416 views
1 citation

Original Research

Published on 07 Jan 2025

Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in South Africa

in Drugs Outcomes Research and Policies

Rochelle Woudberg
Edina Sinanovic

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1511603

1,362 views

Original Research

Published on 07 Jan 2025

Pharmacists’ perceptions of the new pharmaceutical vaccination service in Romania: a comprehensive first two-years evaluation

in Drugs Outcomes Research and Policies

Corneliu-Florin Buicu
Mihaela-Simona Naidin
Marius Calin Chereches
Marina-Daniela Dimulescu
Adina Turcu-Stiolica

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476504

2,159 views

Original Research

Published on 07 Jan 2025

Correlation between the white blood cell/platelet ratio and 28-day all-cause mortality in cardiac arrest patients: a retrospective cohort study based on machine learning

in Drugs Outcomes Research and Policies

Huai Huang
Guangqin Ren
Shanghui Sun
Zhi Li
Yongtian Zheng
Lijuan Dong
Shaoliang Zhu
Xiaosheng Zhu
Wenyu Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1527664

2,027 views

Original Research

Published on 07 Jan 2025

Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in the Chinese healthcare system

in Drugs Outcomes Research and Policies

Wenwang Lang
Yulong He
Changchun Hou
Hua Li
Qinling Jiang
Liuyong Mei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1402423

1,140 views
1 citation

Original Research

Published on 06 Jan 2025

A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer

in Drugs Outcomes Research and Policies

Jie Fu
Yi-Dan Yan
Xu Wan
Xiao-Fan Sun
Xiu-Mei Ma
Ying-Jie Su

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516735

1,877 views

Systematic Review

Published on 06 Jan 2025

Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Shipeng Zhang
Tianyi Dong
Jiawen Xian
Xinyue Xiao
Jiaqing Yuan
Tong Zeng
Kuan Deng
Rui Fu
Hanyu Wang
Yanjie Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519522

1,345 views

Review

Published on 06 Jan 2025

Comparing efficacy and safety of low-dose versus standard-dose antiplatelet therapy in stroke patients: a meta-analysis

in Drugs Outcomes Research and Policies

Zhao Ren
Chunxing Li
Xin Zhang
Lichaoyue Sun
Hui Zhu
Dongxiao Wang
Yumin Wang
Shuo Liang
Guanchun Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1484130

1,175 views

Review

Published on 03 Jan 2025

Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review

in Drugs Outcomes Research and Policies

Chao Wang
Yunzhuo Dong
Peng Men
Ruixia Zhang
Ying Xiao
Yishan Bu
Yinpeng Qin
Xinran Zhang
Qianqian Dou
Yiheng Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426772

1,968 views

Review

Published on 24 Dec 2024

Cutaneous adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Junhui Qian
Jinlong Wan
Qin Yao
Yin Chen
Tao Ling
Yuejuan Zhang
Zhihua Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457226

1,564 views

Original Research

Published on 23 Dec 2024

Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years

in Drugs Outcomes Research and Policies

Przemyslaw Kardas
Bryan Bennett
Bijan Borah
Michel Burnier
Christopher Daly
Mickael Hiligsmann
Enrica Menditto
Andrew M. Peterson
Julia F. Slejko
Krisztina Tóth

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444012

6,500 views
1 citation

Original Research

Published on 20 Dec 2024

Cost-effectiveness analysis of first-line combination chemotherapy regimens for metastatic pancreatic cancer and evidence-based pricing strategy of liposomal irinotecan in China

in Drugs Outcomes Research and Policies

Zuojuan Xiang
Ling Ma
Zhengxiong Li
Yingzhou Fu
Yong Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488645

1,685 views